TransUnion
NYSE:TRUConsulting Services
-$4.48 today
- Market cap
- $14.46B
- Beta
- 1.55
- P/E (TTM)
- 17.6
- EPS (TTM)
- $3.66
- Dividend yield
- 0.74%
Volume 2.45M
Average 2.19M
TRU Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
TransUnionNYSE: TRU
Gross Margin · Q2 FY2026 · quarter ended Jun 2026
Gross margin widens to 58.4%
Gross margin was 58.4% in Q2 FY2026, up 12.2 pp from a year earlier. On a trailing-twelve-month basis it was 55.8%, down 0.2 pp year over year. Over 3 fiscal years it narrowed by 3.6 pp.
Context
- Gross margin widened in 0 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 59.1%
- Year-over-year change
- -0.9pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 59.1% | -0.9pp |
| FY2024 | 2024-12-31 | 60.0% | -0.4pp |
| FY2023 | 2023-12-31 | 60.4% | -2.3pp |
| FY2022 | 2022-12-31 | 62.7% | -2.8pp |
| FY2021 | 2021-12-31 | 65.5% | — |
Gross Margin vs competitors
How TRU compares with its peers on the latest reported figures
- TRU's LTM Jun 2026 gross margin of 55.8% is the 5th highest of the 6 companies compared; the peer median is 70.9%.
- Its year-over-year change of -0.2 pp is the 4th highest of 6, against a peer median of +1.2 pp.
- Over three fiscal years its change of -3.6 pp compares with a peer median of +3.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 85.1% | +3.4 pp | +4.2 pp | |
| LTM Sep 2026 | 73.1% | +5.6 pp | +3.7 pp | |
| LTM Jun 2026 | 70.9% | +1.2 pp | +3.8 pp | |
| LTM Jun 2026 | 67.7% | -1.7 pp | +2.9 pp | |
| LTM Jun 2026 | 55.8% | -0.2 pp | -3.6 pp | |
| LTM Sep 2026 | 55.2% | -1.1 pp | -1.0 pp | |
| Peer median (excluding TRU) | 70.9% | +1.2 pp | +3.7 pp | |
Competitors are the stored peer set for TRU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.96B | 3.71B | 3.83B | 4.18B | 4.58B |
| Cost of Revenue | 1.02B | 1.39B | 1.52B | 1.67B | 1.87B |
| Gross Profit | 1.94B | 2.32B | 2.31B | 2.51B | 2.7B |
| Gross Margin | 65.5% | 62.7% | 60.4% | 60.0% | 59.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 909M | 1.15B | 1.17B | 1.24B | 1.26B |
| Operating Expenses | 1.29B | 1.7B | 2.19B | 1.84B | 1.85B |
| Depreciation & Amortization | 377M | 519M | 524.4M | 537.8M | 574.8M |
| EBITDA | 995.2M | 1.13B | 667.3M | 1.2B | 1.45B |
| EBITDA Margin | 33.6% | 30.5% | 17.4% | 28.8% | 31.8% |
| Operating Income | 651.9M | 626.3M | 128.5M | 666.7M | 857.8M |
| Operating Margin | 22.0% | 16.9% | 3.4% | 15.9% | 18.7% |
| Interest Income | 3.4M | 4.7M | 20.7M | 28.5M | 33.2M |
| Interest Expense | 132.2M | 230.9M | 288.2M | 265.2M | 235.8M |
| Other Income / Expenses | (146.3M) | (243.3M) | (273.8M) | (265.6M) | (214.8M) |
| Income Before Tax | 505.6M | 383M | (145.3M) | 401.1M | 643M |
| Pre-Tax Margin | 17.1% | 10.3% | -3.8% | 9.6% | 14.1% |
| Income Tax Expense | 131.9M | 118.9M | 44.7M | 98.8M | 173.1M |
| Net Income | 1.39B | 266.3M | (206.2M) | 284.4M | 455.4M |
| Net Margin | 47.0% | 7.2% | -5.4% | 6.8% | 10.0% |
| EPS (Basic) | 7.25 | 1.40 | (1.07) | 1.46 | 2.34 |
| EPS (Diluted) | 7.19 | 1.40 | (1.07) | 1.45 | 2.32 |
| Weighted Avg Shares | 191.4M | 192.5M | 193.4M | 194.4M | 194.4M |
| Weighted Avg Shares (Diluted) | 193M | 193.1M | 193.4M | 196.7M | 196.6M |
TransUnion
NYSE:TRU
Intrinsic Alpha fair value
Locked
Current Price
$75.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.